Phenytoin—Folic Acid: A Review
Drug Intelligence & Clinical Pharmacy · 1984-04 · 18 (4) · 292-301
DOI: 10.1177/106002808401800404 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Intelligence & Clinical Pharmacy, online erschienen am 01.04.1984. Verfasst von M P Rivey und 2 weiteren Autor:innen. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 145 Literaturangaben. Gefördert von: PHS HHS.
Abstract (Originalsprache)
The nutrient-drug interaction between folate and phenytoin is a two-way interaction. Folate deficiency resulting from long-term phenytoin therapy is a common occurrence, but progression of the deficiency to a megaloblastic anemia is rare. However, there are data to suggest nonanemic folate deficiency may be detrimental to the patient. Several mechanisms have been proposed to explain the ability of phenytoin to deplete body folate. The supplementation of folic acid to folate-deficient patients taking phenytoin has been shown to result in lowered serum concentrations of phenytoin, and possibly loss of control of the seizure disorder. Folate appears to be associated with the hepatic metabolism of phenytoin, although the effect of folic acid supplementation on phenytoin elimination kinetics is suggested to be individualized.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Förderung
- PHS HHS
Zitieren
APA
Rivey, M. P., Schottelius, D. D., & Berg, M. J. (1984). Phenytoin—Folic Acid: A Review. Drug Intelligence & Clinical Pharmacy, 18(4), 292-301. https://doi.org/10.1177/106002808401800404
Vancouver
Rivey MP, Schottelius DD, Berg MJ. Phenytoin—Folic Acid: A Review. Drug Intelligence & Clinical Pharmacy. 1984;18(4):292-301. doi:10.1177/106002808401800404
BibTeX
@article{Rivey1984,
author = {Rivey, M P and Schottelius, D D and Berg, M J},
title = {Phenytoin—Folic Acid: A Review},
journal = {Drug Intelligence & Clinical Pharmacy},
year = {1984},
volume = {18},
number = {4},
pages = {292--301},
doi = {10.1177/106002808401800404}
}
EUVIMED